Full Text View
Tabular View
No Study Results Posted
Related Studies
Phase I/II Trial of Modified Vaccinia Virus Ankara (MVA) Vaccine Against Smallpox
This study has been completed.
Study NCT00053742   Information provided by National Institutes of Health Clinical Center (CC)
First Received: February 4, 2003   Last Updated: March 3, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Healthy
Additional conditions recognized in this trial
Vaccinia
More general conditions related to this trial
DNA Virus Infections
Poxviridae Infections
Virus Diseases
Sponsors listed in this trial
National Institute of Allergy and Infectious Diseases (NIAID)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services